Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

122,659 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of 2 Different Drug-Coated Balloons in In-Stent Restenosis: The RESTORE ISR China Randomized Trial.
Chen Y, Gao L, Qin Q, Chen S, Zhang J, Chen H, Wang L, Jin Z, Zheng Y, Zhang Z, Li H, Li X, Fu G, Chen L, Sun Z, Wang Y, Jin Q, Cao F, Guo J, Zhao Y, Guan C, Li W, Xu B; RESTORE ISR China Investigators. Chen Y, et al. Among authors: li w, li h, li x. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2368-2377. doi: 10.1016/j.jcin.2018.09.010. JACC Cardiovasc Interv. 2018. PMID: 30522665 Free article. Clinical Trial.
Safety and efficacy of biodegradable polymer-coated sirolimus-eluting stents in "real-world" practice: 18-month clinical and 9-month angiographic outcomes.
Han Y, Jing Q, Xu B, Yang L, Liu H, Shang X, Jiang T, Li Z, Zhang H, Li H, Qiu J, Liu Y, Li Y, Chen X, Gao R; CREATE (Multi-Center Registry of Excel Biodegradable Polymer Drug-Eluting Stents) Investigators. Han Y, et al. Among authors: li y, li z, li h. JACC Cardiovasc Interv. 2009 Apr;2(4):303-9. doi: 10.1016/j.jcin.2008.12.013. JACC Cardiovasc Interv. 2009. PMID: 19463441 Free article. Clinical Trial.
Drug-Coated Balloon Versus Drug-Eluting Stent for Small-Vessel Disease: The RESTORE SVD China Randomized Trial.
Tang Y, Qiao S, Su X, Chen Y, Jin Z, Chen H, Xu B, Kong X, Pang W, Liu Y, Yu Z, Li X, Li H, Zhao Y, Wang Y, Li W, Tian J, Guan C, Xu B, Gao R; RESTORE SVD China Investigators. Tang Y, et al. Among authors: li w, li x, li h. JACC Cardiovasc Interv. 2018 Dec 10;11(23):2381-2392. doi: 10.1016/j.jcin.2018.09.009. JACC Cardiovasc Interv. 2018. PMID: 30522667 Free article. Clinical Trial.
Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: Final five-year results of the patient-level pooled analysis from the TARGET I and TARGET II trials.
Li C, Guan C, Zhang R, Yang Y, Ma C, Li H, Chen S, Han Y, Xu B, Gao R; TARGET Investigators. Li C, et al. Among authors: li h. Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):818-824. doi: 10.1002/ccd.28051. Epub 2018 Dec 18. Catheter Cardiovasc Interv. 2019. PMID: 30565397
A drug-eluting Balloon for the trEatment of coronarY bifurcatiON lesions in the side branch: a prospective multicenter ranDomized (BEYOND) clinical trial in China.
Jing QM, Zhao X, Han YL, Gao LL, Zheng Y, Li ZQ, Yang P, Cong HL, Gao CY, Jiang TM, Li H, Li JX, Wang DM, Wang G, Cong ZC, Zhang Z. Jing QM, et al. Among authors: li jx, li h, li zq. Chin Med J (Engl). 2020 Apr 20;133(8):899-908. doi: 10.1097/CM9.0000000000000743. Chin Med J (Engl). 2020. PMID: 32265425 Free PMC article. Clinical Trial.
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.
Chen Y, Yin T, Xi S, Zhang S, Yan H, Tang Y, Qian J, Chen J, Su X, Du Z, Wang L, Qin Q, Gao C, Zheng Y, Zhao X, Cheng X, Li Z, Zhang W, Chen H, Wang J, Yang Z, Li H, Liu H, Zhou X, Qu B, Xiang D, Guo Y, Wang L, Nie S, Fu G, Yang M, Cai S. Chen Y, et al. Among authors: li z, li h. Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21. Catheter Cardiovasc Interv. 2019. PMID: 31112635
Two-year follow-up of a randomized multicenter study comparing a drug-coated balloon with a drug-eluting stent in native small coronary vessels: The RESTORE Small Vessel Disease China trial.
Tian J, Tang YD, Qiao S, Su X, Chen Y, Jin Z, Chen H, Xu B, Kong X, Pang W, Liu Y, Yu Z, Li X, Li H, Zhao Y, Wang Y, Li W, Guan C, Gao R, Xu B; RESTORE SVD China Investigators. Tian J, et al. Among authors: li w, li x, li h. Catheter Cardiovasc Interv. 2020 Feb;95 Suppl 1:587-597. doi: 10.1002/ccd.28705. Epub 2020 Jan 13. Catheter Cardiovasc Interv. 2020. PMID: 31943693 Clinical Trial.
A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.
Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. Among authors: li w, li h. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.
Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
Tao L, Li Z, Yin Z, Lin W, Liu Y, Li H, Yu B, Li W, Xu B; RECOVERY Trial Investigators. Tao L, et al. Among authors: li z, li w, li h. Catheter Cardiovasc Interv. 2021 May 1;97 Suppl 2:966-975. doi: 10.1002/ccd.29553. Epub 2021 Feb 19. Catheter Cardiovasc Interv. 2021. PMID: 33605036 Clinical Trial.
122,659 results
You have reached the last available page of results. Please see the User Guide for more information.